AJANTPHARM — Ajanta Pharma Share News
0.000.00%
- IN₹410.29bn
- IN₹405.00bn
- IN₹54.53bn
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility
India's Ajanta Pharma promoter sells stake worth about 10.24 billion rupees
India's pharma stocks log best week since March 2025 on strong earnings, April sales
India's Ajanta Pharma rises on strong fourth-quarter, broker optimism
Brief: Ajanta Pharma March-Quarter Consol Profit 2.67 Billion Rupees
Brief: Ajanta Pharma Says US FDA Issues Form-483 With 5 Observations At Ajanta Pharma Paithan Facility
Brief: Ajanta Pharma Ltd Issues Clarification On Media Report
Brief: Ajanta Pharma Denies Considering Stake Acquisition In Restaurant Brands Asia
Everstone to sell stake in India's Burger King operator Restaurant Brands Asia, sources say
India's Ajanta Pharma rises as Motilal Oswal sees strong gains from new weight-loss drug
India's Ajanta Pharma gains on Biocon weight-loss drug marketing pact
Brief: Ajanta Pharma - Signs In-Licensing Agreement With Biocon For Semaglutide
Brief: Ajanta Pharma Sept-Quarter Consol Net Profit 2.6 Billion Rupees
Indian pharma stocks drop 1% after Trump signs order to boost US drug manufacturing
Brief: Ajanta Pharma March-Quarter Consol Profit 2.25 Bln Rupees
India's Ajanta Pharma gains after Jefferies starts coverage with 'buy'